Jerry Colca

Company: Cirius Therapeutics

Job title: Chief Scientific Officer

Seminars:

New Insulin Sensitizers as a Golden Combination With Glp-1 & Weight Loss Therapies 9:30 am - 10:00 am

Discussing novel oral insulin sensitizers targeting the mitochondrial pyruvate carrier to improve insulin sensitivity by shifting mitochondrial metabolism, increasing insulin response, and enhancing mitochondrial function Exploring insulin sensitizers beyond glycaemic control such as their potential to increase lean muscle mass and inflammation modulation Developing potent insulin-sensitising drugs that can be used in combination with GLP-1…Read more

day: Day One

Roundtable Discussion: Subcutaneous Vs Oral Administration in GLP-1: Will Oral Administration Really Improve Patient Adherence? 4:00 pm - 4:30 pm

Examining the benefits and challenges of oral GLP-1 delivery, considering gastrointestinal degradation, first pass metabolism and formulation challenges Comparing the efficacy and safety profiles of glycaemic control in oral and subcutaneous GLP-1s Exploring real world evidence and data on patient adherence to injectables and oral medication – will the oral delivery make the side effects…Read more

day: Day One